Quantcast

Latest Raloxifene Stories

2009-02-03 08:03:00

NCCN announces new updates to the NCCN Guidelines for Breast Cancer and Breast Cancer Risk Reduction Guidelines. Noteworthy additions include new recommendations on when to use MRIs in breast cancer evaluations, statements discouraging the use of PET/CT scanning for evaluative purposes, and new cosmetic recommendations for women undergoing reconstructive surgery. FORT WASHINGTON, Pa., Feb. 3 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) announces important...

2008-09-25 09:00:16

COLLEGEVILLE, Pa., Sept. 25 /PRNewswire/ -- A retrospective analysis of Phase 3 two-year data presented at the annual meeting of the North American Menopause Society (NAMS) suggest that postmenopausal women treated with bazedoxifene/conjugated estrogens (BZA/CE) may experience incidence of breast tenderness and abnormal mammograms no greater than those treated with placebo. BZA/CE is an investigational compound being studied by Wyeth Pharmaceuticals, a division of Wyeth , for the treatment...

2008-08-22 03:00:10

By Solimeo, Samantha Osteoporosis is a metabolic bone disorder characterized by low bone density and associated with atraumatic fractures, pain, disability, long-term-care placement, and premature mortality. The condition is an important public health issue for all older adults, but the construction of osteoporosis as a "women's disease," and men's behavior in response, may limit the efficacy of current screening and treatment options for men. Though men are indeed at risk for osteoporosis,...

2008-06-24 09:02:03

The North American Menopause Society (NAMS) has just released a supplement to its official journal Menopause to meet the need for current clinical recommendations for managing breast cancer risk in postmenopausal women. Breast cancer is the most common cancer among women, except for nonmelanoma skin cancers, and is the second leading cause of cancer death for women worldwide. According to the American Cancer Society, 182,460 new cases of invasive breast cancer will be diagnosed in US...

2007-08-30 06:19:04

By Verdier-Sevrain, S ABSTRACT Estrogens have a profound influence on skin. The relative hypoestrogenism that accompanies menopause exacerbates the deleterious effects of both intrinsic and environmental aging. Estrogens prevent skin aging. They increase skin thickness and improve skin moisture. Beneficial effects of hormone replacement therapy (HRT) on skin aging have been well documented, but HRT cannot obviously be recommended solely to treat skin aging in menopausal women. Topical...

2007-03-09 09:00:22

By Zaborowska, E; Brynhildsen, J; Damberg, S; Fredriksson, M; Et al Key words: VASOMOTOR SYMPTOMS, HOT FLUSHES, ACUPUNCTURE, APPLIED RELAXATION, PLACEBO ABSTRACT Objective To assess if transdermal or oral estrogens, acupuncture and applied relaxation decrease the number of menopausal hot flushes/ 24 h and improve climacteric symptoms, as assessed by the Kupperman index, more than transdermal placebo treatment. Setting An outpatient clinic at a Swedish university hospital. Methods A...

2007-01-10 03:00:00

By Scharla, S; Oertel, H; Helsberg, K; Kessler, F; Et al Key words: Analgesia - Bone pain - Osteoporosis, postmenopausal - Raloxifene ABSTRACT Objective: To assess the prevalence of skeletal pain in postmenopausal women before the onset of raloxifene treatment and the further course of pain during treatment in a naturalistic setting. Research design and methods: Prospective, uncontrolled, multicentre, 6-month, observational study in Germany. Clinical, diagnostic and pain data were...

2006-07-24 08:05:00

WASHINGTON -- Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives, U.S. researchers reported on Monday. Women at the highest risk of breast cancer do appear to live longer if they take tamoxifen, the researchers report in the latest issue of the journal Cancer. But for women at the low end of the high risk group, the sometimes serious side effects of tamoxifen outweigh the benefits, Dr. Joy Melnikow of the University of...

2006-05-25 10:24:13

NEW YORK (Reuters Health) - Treatment with raloxifene appears to reduce heart rate variability in elderly women with osteoporosis, Turkish researchers report in the American Journal of Obstetrics and Gynecology. There is some evidence that raloxifene, sold under the trade name Evista, may have a protective effect on women with cardiovascular disease or who have a high risk of developing cardiovascular disease, but the effects are still unclear, Dr. Mert Gol and colleagues at Dokuz...

2006-04-18 11:30:00

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - The osteoporosis drug Evista works as well as tamoxifen in reducing the risk of breast cancer in high-risk older women, with fewer dangerous side effects, researchers said on Monday. Both drugs reduce the risk of breast cancer in high-risk women past menopause by about 50 percent, the researchers said. And the results of the 19,000-woman trial show that Eli Lilly and Co's Evista, known generically as raloxifene, is less...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related